Association of plasma amyloid-β oligomerization with theta/beta ratio in older adults

Association of plasma amyloid-β oligomerization with theta/beta ratio in older adults

BackgroundOligomeric Aβ (OAβ) is a promising candidate marker for Alzheimer’s disease (AD) diagnosis. Electroencephalography (EEG) is a potential tool for early detection of AD. Still, whether EEG power ratios, particularly the theta/alpha ratio (TAR) and theta/beta ratio (TBR), reflect Aβ burden—a...

Full description

Bibliographic Details
Main Authors:	Heewon Bae, Min Ju Kang, Sang-Won Ha, Da-Eun Jeong, Kiwon Lee, Seungui Lim, Jin-Young Min, Kyoung-Bok Min
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Aging Neuroscience
Subjects:	amyloid oligomers EEG Alzheimer’s disease cognitive impairment neurotox
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2023.1291881/full

Similar Items

Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
by: David L. Brody, et al.
Published: (2017-08-01)

Structural mapping of oligomeric intermediates in an amyloid assembly pathway
by: Theodoros K Karamanos, et al.
Published: (2019-09-01)

Use of electroencephalogram, gait, and their combined signals for classifying cognitive impairment and normal cognition
by: Jin-Young Min, et al.
Published: (2022-09-01)

Corrigendum: Use of electroencephalogram, gait, and their combined signals for classifying cognitive impairment and normal cognition
by: Jin-Young Min, et al.
Published: (2023-12-01)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
by: Min Jeong Wang, et al.
Published: (2017-12-01)

Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis
by: Botond Penke, et al.
Published: (2020-04-01)

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
by: Pyun JM, et al.
Published: (2021-04-01)

Oligomeropathies, inflammation and prion protein binding
by: Gianluigi Forloni, et al.
Published: (2022-08-01)

Antibody Fragments as Tools for Elucidating Structure-Toxicity Relationships and for Diagnostic/Therapeutic Targeting of Neurotoxic Amyloid Oligomers
by: André L. B. Bitencourt, et al.
Published: (2020-11-01)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
by: Young Chul Youn, et al.
Published: (2019-05-01)

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data
by: Young Chul Youn, et al.
Published: (2022-11-01)

Oligomerization by co-assembly of β-amyloid and α-synuclein
by: Jin Ryoun Kim
Published: (2023-03-01)

Association of Plasma Oligomerized Beta Amyloid with Neurocognitive Battery Using Korean Version of Consortium to Establish a Registry for Alzheimer’s Disease in Health Screening Population
by: Jung-Ju Lee, et al.
Published: (2020-04-01)

Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia
by: Wataru Araki, et al.
Published: (2022-01-01)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
by: Seong Soo A. An, et al.
Published: (2017-10-01)

Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue
by: Sylvain E. Lesne
Published: (2014-11-01)

Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
by: Raquel Sanchez-Varo, et al.
Published: (2021-11-01)

Pore formation by human stefin B in its native and oligomeric states and the consequent amyloid induced toxicity.
by: Gregor eAnderluh, et al.
Published: (2012-08-01)

5-Hydroxycyclopenicillone Inhibits β-Amyloid Oligomerization and Produces Anti-β-Amyloid Neuroprotective Effects In Vitro
by: Jiaying Zhao, et al.
Published: (2017-10-01)

Amyloid Beta Oligomers-Induced Ca<sup>2+</sup> Entry Pathways: Role of Neuronal Networks, NMDA Receptors and Amyloid Channel Formation
by: Erica Caballero, et al.
Published: (2022-05-01)

L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease
by: Thimmappa S. Anekonda, et al.
Published: (2011-01-01)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
by: Kenjiro Ono, et al.
Published: (2019-05-01)

Role of Electrostatic Interactions in Calcitonin Prefibrillar Oligomer-Induced Amyloid Neurotoxicity and Protective Effect of Neuraminidase
by: Ida Cariati, et al.
Published: (2021-04-01)

Activation of STAT3 Regulates Reactive Astrogliosis and Neuronal Death Induced by AβO Neurotoxicity
by: Danira Toral-Rios, et al.
Published: (2020-10-01)

Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils
by: Martin Muschol, et al.
Published: (2023-02-01)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
by: Heinz Hillen
Published: (2023-01-01)

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status
by: Keun You Kim, et al.
Published: (2022-11-01)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
by: Rosha Babapour Mofrad, et al.
Published: (2021-07-01)

Reversible peptide oligomerization over nanoscale gold surfaces
by: Kazushige Yokoyama, et al.
Published: (2015-11-01)

Three Structural Features of Functional Food Components and Herbal Medicine with Amyloid β42 Anti-Aggregation Properties
by: Kazuma Murakami, et al.
Published: (2019-06-01)

A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
by: Sun LP, et al.
Published: (2018-02-01)

Sesamol as a potential small molecule in inhibiting the induction of neurotoxic amyloids fibrils involved in the pathophysiology of alzheimer's disease
by: Hong-Bin Cai, et al.
Published: (2023-09-01)

Editorial: Oligomers in amyloid-associated diseases—structural properties and toxicity
by: Neville Vassallo, et al.
Published: (2023-06-01)

Oligomeric State and Holding Activity of Hsp60
by: Celeste Caruso Bavisotto, et al.
Published: (2023-04-01)

Applications of Single-Molecule Vibrational Spectroscopic Techniques for the Structural Investigation of Amyloid Oligomers
by: Katrin Ha Phuong Vu, et al.
Published: (2022-09-01)

Sinomenine inhibits amyloid beta-induced astrocyte activation and protects neurons against indirect toxicity
by: Deepali Singh, et al.
Published: (2020-03-01)

Protective effects of some medicinal plants from Lamiaceae family against beta-amyloid induced toxicity in PC12 cell
by: Balali P, et al.
Published: (2012-10-01)

Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review
by: Maria Fernanda Avila-Vazquez, et al.
Published: (2017-12-01)

Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC
by: Ibrahim Javed, et al.
Published: (2020-09-01)

Amyloid-β Oligomers: Multiple Moving Targets
by: Dylan Shea, et al.
Published: (2022-04-01)